Bumper Offer - Urjas oil Just @ Rs. 1
Glynase Mf is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Glynase Mf have also been mentioned below.
The optimal dosage of Glynase Mf is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Glynase Mf include Stomach Upset, Difficulty urinating. Besides the aforementioned side effects, there are other adverse effects of Glynase Mf as well, which are listed below. Normally, these side effects of Glynase Mf are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Glynase Mf has a Mild effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Glynase Mf related warnings talks about Glynase Mf's effects on the liver, heart and kidney.
Glynase Mf is contraindicated in people with pre-existing medical conditions like Liver Disease, Heart Disease, Kidney Disease as it can result in adverse effects. Other conditions have been mentioned below in the Glynase Mf contraindications section.
Besides this, Glynase Mf may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Glynase Mf is safe while driving, and is addiction.
Glynase Mf is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Glynase Mf is used -
Severe
Moderate
Mild
Common
Is the use of Glynase Mf safe for pregnant women?
Pregnant women may get mild side effects from Glynase Mf.
Is the use of Glynase Mf safe during breastfeeding?
Glynase Mf can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Glynase Mf on the Kidneys?
Using Glynase Mf does not have any harmful effects on kidneys.
What is the effect of Glynase Mf on the Liver?
Glynase Mf does not damage the liver.
What is the effect of Glynase Mf on the Heart?
You can take Glynase Mf without any fear of damage to the heart.
Glynase Mf should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glynase Mf unless your doctor advises you to do so -
Is this Glynase Mf habit forming or addictive?
Glynase Mf does not cause addiction.
Interaction between Food and Glynase Mf
Due to the absence of research, it is difficult to say how Glynase Mf and food will interact.
Interaction between Alcohol and Glynase Mf
Taking alcohol with Glynase Mf can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucotrol - glipizide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826